|
| 36179990 | External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis. | Int J Radiat Oncol Biol Phys | 2023 |
| 36889593 | Outcomes after PD-103 versus I-125 for low dose rate prostate brachytherapy monotherapy: An international, multi-institutional study. | Radiother Oncol | 2023 |
| 34656435 | <sup>125</sup>I Interstitial brachytherapy with or without androgen deprivation therapy among unfavorable-intermediate and high-risk prostate cancer. | Brachytherapy | 2022 |
| 35718634 | Coronary intravascular brachytherapy for in-stent restenosis: A review of the contemporary literature. | Brachytherapy | 2022 |
| 35050303 | Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts. | JAMA Oncol | 2022 |
| 34196715 | Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features. | JAMA Netw Open | 2021 |
| 34902034 | Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer. | JAMA Netw Open | 2021 |
| 33985797 | Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. | Eur Urol | 2021 |
| 30992160 | Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. | Eur Urol | 2020 |
| 31813740 | Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy. | Brachytherapy | 2020 |
| 32442822 | A biochemical definition of cure after brachytherapy for prostate cancer. | Radiother Oncol | 2020 |
| 30446400 | Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With Radiotherapy. | Clin Genitourin Cancer | 2019 |
| 31523238 | Addition of magnetic resonance imaging to real time trans-rectal ultrasound-based treatment planning for prostate implants. | J Contemp Brachytherapy | 2019 |
| 31059665 | Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy. | J Urol | 2019 |
| 30721720 | Ten-Year Outcomes of Moderately Hypofractionated (70Â Gy in 28 fractions) Intensity Modulated Radiation Therapy for Localized Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2019 |
| 29509865 | Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. | JAMA | 2018 |
| 29890234 | Principles and practice of high-dose rate penile brachytherapy: Planning and delivery techniques. | Pract Radiat Oncol | 2018 |
| 29976500 | Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study. | Int J Radiat Oncol Biol Phys | 2018 |
| 30652549 | An Approach to Identify Delivery of Palliative Radiation Therapy Using Health Care Claims Data: A Proof-of-Concept Application of a Visual Analytics Tool. | JCO Clin Cancer Inform | 2018 |
| 27593476 | Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment. | J Urol | 2017 |
| 28333019 | A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2017 |
| 28419139 | Skeletal-related events and mortality among men diagnosed with advanced prostate cancer: The impact of alternative measures of radiation to the bone. | PLoS One | 2017 |
| 28882777 | Secondary Urethral Malignancies Following Prostate Brachytherapy. | Urology | 2017 |
| 28816155 | In Reply to Morris and Tyldesley. | Int J Radiat Oncol Biol Phys | 2017 |
| 26166626 | A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. | Eur Urol | 2016 |
| 27663760 | Multinational Prospective Study of Patient-Reported Outcomes After Prostate Radiation Therapy: Detailed Assessment of Rectal Bleeding. | Int J Radiat Oncol Biol Phys | 2016 |
| 27681757 | Posttreatment Prostate-Specific Antigen 6Â Months After Radiation With Androgen Deprivation Therapy Predicts for Distant Metastasis-Free Survival and Prostate Cancer-Specific Mortality. | Int J Radiat Oncol Biol Phys | 2016 |
| 27302520 | In Regard to Viani et al. | Int J Radiat Oncol Biol Phys | 2016 |
| 26796717 | Outcomes for prostate glands >60 cc treated with low-dose-rate brachytherapy. | Brachytherapy | 2016 |
| 26972639 | High-Dose-Rate Monotherapy for Localized Prostate Cancer-What More Will It Take to Make This a Standard Therapy? | Int J Radiat Oncol Biol Phys | 2016 |
| 25301759 | Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy. | Eur Urol | 2015 |
| 26276528 | Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy. | Radiother Oncol | 2015 |
| 26622225 | Safety and efficacy of salvage low-dose-rate brachytherapy for prostate bed recurrences following radical prostatectomy. | J Contemp Brachytherapy | 2015 |
| 25829932 | Influence of zonal dosimetry on prostate brachytherapy outcomes. | J Contemp Brachytherapy | 2015 |
| 25899222 | Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis. | Pract Radiat Oncol | 2015 |
| 25962627 | Long-Term Efficacy and Toxicity of Low-Dose-Rate ¹²âµI Prostate Brachytherapy as Monotherapy in Low-, Intermediate-, and High-Risk Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2015 |
| 25571871 | Evaluation of the current prostate cancer staging system based on cancer-specific mortality in the surveillance, epidemiology, and end results database. | Clin Genitourin Cancer | 2015 |
| 25294696 | Are biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrence. | Eur Urol | 2015 |
| 24169495 | Future directions from past experience: a century of prostate radiotherapy. | Clin Genitourin Cancer | 2014 |
| 24969804 | In reply to Jones and Menon. | Int J Radiat Oncol Biol Phys | 2014 |
| 24577815 | Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation. | J Natl Cancer Inst | 2014 |
| 24315301 | Outcomes after photoselective vaporization of the prostate and transurethral resection of the prostate in patients who develop prostatic obstruction after radiation therapy. | Urology | 2014 |
| 23561651 | Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. | Int J Radiat Oncol Biol Phys | 2013 |
| 24674405 | Late toxicity after intensity modulated and image guided radiation therapy for localized prostate cancer and post-prostatectomy patients. | Pract Radiat Oncol | 2013 |
| 24074916 | High-risk prostate cancer in the modern era: does a single standard of care exist? | Int J Radiat Oncol Biol Phys | 2013 |
| 23920389 | Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer. | Int J Radiat Oncol Biol Phys | 2013 |
| 23506834 | Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity. | Eur Urol | 2013 |
| 23565244 | PARP inhibition sensitizes to low dose-rate radiation TMPRSS2-ERG fusion gene-expressing and PTEN-deficient prostate cancer cells. | PLoS One | 2013 |
| 21665379 | Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy. | Int J Radiat Oncol Biol Phys | 2012 |
| 22698472 | Editorial comment. | Urology | 2012 |